Effectiveness and Safety of Percutaneous Adhesiolysis Using Rac'z Catheter Versus Navi Catheter i… (NCT05018377) | Clinical Trial Compass
CompletedNot Applicable
Effectiveness and Safety of Percutaneous Adhesiolysis Using Rac'z Catheter Versus Navi Catheter in Management of Failed Back Surgery Syndrome
Egypt60 participantsStarted 2021-09-01
Plain-language summary
In the past decade, spine surgery rates have dramatically increased in parallel to those of other procedural interventions. Persistent pain is a common occurrence after spine surgery, with the most commonly quoted prevalence rates ranging from 10% to 40%. This pain can be classified into failure to alleviate baseline pain, pain resulting from complications (e.g., arachnoiditis and epidural adhesions), and pain that ensues several years later as a sequele to alterations in spinal architecture and biomechanics (e.g., adjacent segment discogenic or facetogenic pain) which is called failed back surgery syndrome ( FBSS )
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with history of lumbar surgery of at least 6 months duration in the past.
* Patients over the 18 years of age.
* History of persistent function-limiting lower extremity pain aggravated by "dural tug" (observed when the patient, sitting on the exam table with legs stretched out, bends forward, bringing on the back pain) with or without low back pain of at least 6 months duration after failure of conventional conservative management in most patients including NSAIDS, muscle relaxants (tizanidine, magnesium sulphate) and pregabalin.
* Patients who are competent to understand the study protocol and provide voluntary, written informed consent and participate in outcome measurements.
Exclusion Criteria:
* Unstable or heavy opioid use.
* Uncontrolled psychiatric disorders.
* Uncontrolled medical illness.
* Any conditions that could interfere with the interpretation of the outcome assessments.
* Pregnant or lactating women.
* Patients with a history or potential for adverse reaction(s) to local anaesthetics or steroid.